| scholarly article | Q13442814 |
| P50 | author | Johann Bauersachs | Q21190988 |
| Keith Channon | Q56420294 | ||
| P2093 | author name string | Andreas Schäfer | |
| Stefan Neubauer | |||
| Frank Wiesmann | |||
| Martin Eigenthaler | |||
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1819-1822 | |
| P577 | publication date | 2004-04-05 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Rapid regulation of platelet activation in vivo by nitric oxide | |
| P478 | volume | 109 |
| Q46954072 | 11,12-Epoxyeicosatrienoic acid activates the L-arginine/nitric oxide pathway in human platelets |
| Q38516928 | Accelerated RBC senescence as a novel pathologic mechanism of blood stasis syndrome in traditional East Asian medicine |
| Q50487280 | Analysis of red blood cell deformation under fast shear flow for better estimation of hemolysis. |
| Q54443448 | Association analysis of CD40 gene polymorphism with acute coronary syndrome. |
| Q38684700 | Cerebral vasospasm in acute porphyria |
| Q36796121 | Changing the way we think about endothelial cell insulin sensitivity, nitric oxide, and the pathophysiology of type 2 diabetes: the FoxO is loose |
| Q33398742 | Drugs that inhibit complement |
| Q34229715 | Ebola hemorrhagic Fever: novel biomarker correlates of clinical outcome |
| Q37956407 | Eculizumab: a review of its use in paroxysmal nocturnal haemoglobinuria |
| Q36955405 | Enhancing cardiovascular dynamics by inhibition of thrombospondin-1/CD47 signaling. |
| Q59136926 | Erythrocytic bioactivation of nitrite and its potentiation by far-red light |
| Q33800427 | Evaluation of hemostasis and endothelial function in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab |
| Q46133367 | Inhibition of platelet activation in rats with severe congestive heart failure by a novel endothelial nitric oxide synthase transcription enhancer |
| Q36969764 | Insulin resistance and endothelial cell dysfunction: studies in mammalian models |
| Q37626438 | Mechanisms of hemolysis-associated platelet activation. |
| Q34958622 | Mechanisms of human erythrocytic bioactivation of nitrite |
| Q34256164 | Metabolomic analyses for atherosclerosis, diabetes, and obesity |
| Q54566349 | Monomeric C-reactive protein is prothrombotic and dissociates from circulating pentameric C-reactive protein on adhered activated platelets under flow. |
| Q52722001 | Nitric oxide pathology and therapeutics in sickle cell disease. |
| Q37887771 | Nitric oxide: a guardian for vascular grafts? |
| Q33532375 | Noninvasive assessment of endothelial function in the skin microcirculation |
| Q42036462 | Paroxysmal nocturnal hemoglobinuria: pathophysiology, natural history and treatment options in the era of biological agents |
| Q35535204 | Pleiotropic effects of intravascular haemolysis on vascular homeostasis |
| Q33681568 | Potential therapeutic action of nitrite in sickle cell disease |
| Q33409045 | ROS-mediated platelet generation: a microenvironment-dependent manner for megakaryocyte proliferation, differentiation, and maturation |
| Q36574160 | Recent advances in biological and clinical aspects of paroxysmal nocturnal hemoglobinuria |
| Q36780187 | Recent developments in the understanding and management of paroxysmal nocturnal haemoglobinuria |
| Q41949334 | Recurrent and progressive abdominal pain and enteritis in a Japanese patient with paroxysmal nocturnal hemoglobinuria |
| Q30275352 | Red Blood Cell Function and Dysfunction: Redox Regulation, Nitric Oxide Metabolism, Anemia |
| Q104486605 | Reduced lifespan of erythrocytes in Dahl/Salt sensitive rats is the cause of the renal proximal tubule damage |
| Q33740877 | Relationship between monocyte-platelet aggregation and endothelial function in middle-aged and elderly adults |
| Q39350639 | Retrospective evaluation of the effect of red blood cell product age on occurrence of acute transfusion-related complications in dogs: 210 cases (2010-2012). |
| Q34571118 | S-Nitrosoglutathione improves haemodynamics in early-onset pre-eclampsia |
| Q36142655 | Statin mediated protection of the ischemic myocardium |
| Q33960556 | Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy |
| Q28579415 | The cannabinoid receptor-1 antagonist rimonabant inhibits platelet activation and reduces pro-inflammatory chemokines and leukocytes in Zucker rats |
| Q28512770 | The critical roles of platelet activation and reduced NO bioavailability in fatal pulmonary arterial hypertension in a murine hemolysis model |
| Q36892494 | The impact of insulin resistance on endothelial function, progenitor cells and repair |
| Q28508627 | The insulin-like growth factor-1 receptor is a negative regulator of nitric oxide bioavailability and insulin sensitivity in the endothelium |
| Q35619474 | The nitric oxide donor pentaerythritol tetranitrate reduces platelet activation in congestive heart failure |
| Q37807986 | The role of IGF-1 resistance in obesity and type 2 diabetes-mellitus-related insulin resistance and vascular disease |
| Q36893543 | The role of red blood cell S-nitrosation in nitrite bioactivation and its modulation by leucine and glucose. |
| Q42348709 | Thrombotic complications without evidence of hemolysis in paroxysmal nocturnal hemoglobinuria: Is eculizumab indicated? |
Search more.